Impact Evaluation of the Use of Community Volunteers and Patent Medicine Vendors for Malaria Control in Anambra State and Gombe State 2014 -2015, Endline Survey
Nigeria, 2014 - 2015
Get MicrodataCreated on
Jan 16, 2021
Last modified
Jan 16, 2021
Page views
78376
Downloads
510
BRAND NAME, INCLUDING DRUG SPECIFICATIONS (brandname_drug6)
Data file: pmv_release
Overview
Valid:
61
Invalid:
0
Type:
Discrete
Start:
5460
End:
5504
Width:
45
Range:
-
Format:
character
Questions and instructions
Categories
| Value | Category | Cases | |
|---|---|---|---|
| ACT | 1 |
1.6%
|
|
| ANATE(amodiaquine+artesunate) | 1 |
1.6%
|
|
| Amalar | 1 |
1.6%
|
|
| Amalar ( sp ) | 3 |
4.9%
|
|
| Amalar(SP) | 1 |
1.6%
|
|
| Amatem Forte ( Artemether and Lumefantrine ) | 1 |
1.6%
|
|
| Artemef (ACT ) | 1 |
1.6%
|
|
| Artemether Lumefantrine | 1 |
1.6%
|
|
| Artemether and Lumefantrine ( Act ) | 2 |
3.3%
|
|
| Artemether and Lumefantrine (Act ) | 1 |
1.6%
|
|
| Artemether lumefantrine (ACT) | 1 |
1.6%
|
|
| Artequin ( Artesunate ) | 1 |
1.6%
|
|
| Artequin (Artesunate and mefloquine) | 1 |
1.6%
|
|
| Artesunat | 1 |
1.6%
|
|
| Artesunat ( Artesunate ) | 1 |
1.6%
|
|
| Artesunat (SP) | 1 |
1.6%
|
|
| Artesunat GMP | 1 |
1.6%
|
|
| Artesunate | 1 |
1.6%
|
|
| Artesunate GMP | 1 |
1.6%
|
|
| Artesunate c.p.50mg ( Artesunate ) | 1 |
1.6%
|
|
| Atmal-Plus (Artemether and Lumefantrine ) | 1 |
1.6%
|
|
| Camosunate ACT | 1 |
1.6%
|
|
| Coartem ACT:-) | 1 |
1.6%
|
|
| Combisunate (ACT) | 1 |
1.6%
|
|
| Fralomin | 1 |
1.6%
|
|
| GRUTHA FORT | 1 |
1.6%
|
|
| Halfan 2x3 | 1 |
1.6%
|
|
| Koyodrine(proguanil tablets B.P) | 1 |
1.6%
|
|
| Laridox (SP) | 1 |
1.6%
|
|
| Laridox (sp ) | 1 |
1.6%
|
|
| Laridox(S.P) | 1 |
1.6%
|
|
| Laridox(sp) | 1 |
1.6%
|
|
| Lifloxin(sp) | 1 |
1.6%
|
|
| Lonart ACT | 1 |
1.6%
|
|
| Lonart-DS | 1 |
1.6%
|
|
| Lonart-DS ( Artemether and Lumefantrine ) | 1 |
1.6%
|
|
| Malareich | 1 |
1.6%
|
|
| Malareich (sp ) | 1 |
1.6%
|
|
| Malareich SP | 1 |
1.6%
|
|
| Maldox | 1 |
1.6%
|
|
| Maldox ( sp ) | 2 |
3.3%
|
|
| Maldox Sp | 1 |
1.6%
|
|
| Maldox(S.P) | 1 |
1.6%
|
|
| Maldox(sp) | 1 |
1.6%
|
|
| Md-artesunate | 1 |
1.6%
|
|
| Melofan (sp ) | 2 |
3.3%
|
|
| Metaquine | 1 |
1.6%
|
|
| Ouimal (chloroquine phosphate) | 1 |
1.6%
|
|
| P-Alaxin ( Dihydroartemisin and piperaquine ) | 1 |
1.6%
|
|
| P-alaxin dihydroartemisinin+piperaquine | 1 |
1.6%
|
|
| Swidar ( sp ) | 1 |
1.6%
|
|
| V-Martem ( Artemether and Lumefantrine ) | 1 |
1.6%
|
|
| Waipa ( ACT ) | 1 |
1.6%
|
|
| Waipa (ACT ) | 1 |
1.6%
|
|
| Waipa (Act) | 1 |
1.6%
|
|
| Waipa(act) | 1 |
1.6%
|
Warning: these figures indicate the number of cases found in the data file. They cannot be interpreted as summary statistics of the population of interest.